Beyond the Drip Podcast cover art

Beyond the Drip Podcast

Beyond the Drip Podcast

Written by: Prochant
Listen for free

About this listen

 Welcome to Beyond the Drip Podcast!Join us as we explore the world of Infusion Pharmacy, including Home Infusion and Ambulatory Infusion Centers. Featuring interviews with industry trailblazers, this podcast is your go-to source for the latest news, trends, innovations, and insights in the infusion industry. Whether you're a healthcare professional or just curious about infusion pharmacy, Beyond the Drip Podcast is here to keep you informed and inspired.

Tune in and take your knowledge beyond the drip!

New podcasts released monthly!Copyright Prochant Politics & Government
Episodes
  • Beyond the Drip: Infusion Strategy and the Road Ahead with Vic Simianu

    Beyond the Drip: Infusion Strategy and the Road Ahead with Vic Simianu
    Dec 16 2025
    Welcome to Beyond the Drip, where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired.     As the year comes to a close, Beyond the Drip delivers a forward-looking conversation on the evolving infusion and specialty pharmacy landscape. In the final episode of the year, our co-hosts sit down with Vic Simianu, CEO and Founder of Sphinx Strategies, to discuss his path into infusion, the mounting pressures on independent pharmacies and what the next three to five years will require from industry leaders. With a background in biotech, finance and early-stage startups, Vic entered specialty pharmacy just as it was emerging as a $60 billion industry, which is now a trillion-dollar market. That experience shaped his decision to launch Sphinx Strategies, recognizing that independent pharmacies needed a way to stay competitive without billion-dollar budgets. Today, Sphinx helps pharmacies strengthen operations, data strategy and long-term growth in an increasingly complex market. Key Takeaways The infusion and specialty pharmacy market has rapidly evolved, increasing pressure on independent providers to adapt and differentiate. Clear value propositions and niche focus are essential as pharmacies face closures and tighter margins. Integrated operations, clinical expertise and data strategy are critical for long-term success and must be driven by leadership. Strong data and disease-state expertise improve access to manufacturers, especially as new cell and gene therapies come to market. Pharmacies should optimize and leverage existing data and workflows before expanding services or sites of care. Site-of-care strategies must align with patient volume, provider preferences and operational scale to be successful. At its core, this episode highlights a clear message: sustainable growth in infusion pharmacy comes from operational excellence, smart data strategy and focused differentiation. Vic explains that Sphinx Strategies partners with pharmacies to identify missing puzzle pieces, whether that’s strategy, valuation, due diligence or long-term planning, so they can stay competitive and build lasting ROI. Don’t miss this final Beyond the Drip episode of the year for a discussion on where infusion pharmacy is headed and how independent providers can position themselves for the future. Tune in now! ---Vic Simianu, Founder & CEO of Sphinx StrategiesVic Simianu is the Founder and CEO of Sphinx Strategies, a consulting group focused on building highly integrated specialty pharmacy operations. One of the industry’s earliest ACHC-Certified Specialty Pharmacy Consultants, Vic brings deep expertise in accreditation strategy, operational excellence, and oncology-focused specialty services. His experience spans independent pharmacies, large IDNs, ACOs, and publicly traded organizations. Vic holds an MBA from Indiana University Kelley School of Business and leads Sphinx Strategies from Boulder, Colorado.Beyond the Drip Co-hosts:Paula Roth, VP of Pharmacy Services at ProchantAs Vice President of Pharmacy Operations at Prochant, Paula leads an expert team focused on enhancing the home-based care industry through innovative technology and streamlined processes. With more than 20 years of experience in revenue cycle management for alternate sites of care, Paula leverages technology and teams to ensure clients achieve or exceed their financial targets.Jon Love, President & Chief Growth Officer at MedEdge Solutions Jon Love joins MedEdge with leadership experience in the infusion and specialty pharmacy industries. He has previously served in sales at WellSky, chief operating officer at Rock-Pond Solutions and senior VP of pharmacy services at Prochant.Pamela McIntyre, founder and owner of Expert Infusion Nurse Consulting With 40 years of experience in infusion nursing, Pam founded Expert Infusion Nurse Consulting to advance excellence in infusion and mentor other infusion professionals. Her certifications include CRNI, IgCN, OCN and VA-BC, and she has an immersive background in home infusion and ambulatory infusion in the fields of acute and chronic care, including oncology nursing. Brandon Carpenter, President of MedEdge Solutions Brandon Carpenter is the owner and founder of MedEdge Solutions. With more than 12 years of experience in pharmacy solutions, process improvement and data analytics, Brandon takes an active role in each of our projects. Prior to forming MedEdge, Brandon was the Director of Products and Professional Services at Rock-Pond Solutions where he worked with over 250 pharmacies nationwide to solve problems ranging from system integrations, financial ...
    Show More Show Less
    1 hr and 1 min
  • Beyond the Drip Podcast: Industry Trailblazer Marc Stranz Reflects on 50 Years of Infusion Pharmacy

    Beyond the Drip Podcast: Industry Trailblazer Marc Stranz Reflects on 50 Years of Infusion Pharmacy
    Nov 14 2025
    In this episode of Beyond the Drip, we sit down with Marc Stranz, PharmD, one of the most influential voices in the infusion pharmacy world. With a career spanning five decades, Marc shares a rare inside look at how sterile compounding and home infusion have evolved—from the early days of parenteral nutrition to the multi-billion-dollar specialty infusion landscape we know today. Marc recounts his beginnings in sterile compounding, the launch of his first home infusion company in the early 1980s, and his leadership roles across national providers including Coram, Bioscrip, and BioMatrix. He also discusses the formation of Stranz Crossley Inc., the consulting firm he cofounded in 2018 that now advises manufacturers, wholesalers, insurers, investors, and providers across the specialty and infusion sectors. Through stories, lessons, and industry insights, Marc reflects on the innovations that shaped infusion pharmacy, the importance of mentorship and collaboration, and what future leaders should prepare for as the field continues to evolve. Whether you're in infusion pharmacy, home infusion, specialty pharmacy, or broader home-based care, this conversation offers invaluable perspective from someone who helped build the industry. Highlights
    • Marc’s unexpected entry into pharmacy and early work in drug information
    • Founding a home infusion company in 1982
    • The shift from glass bottles to advanced home infusion technologies
    • The growth of NHIA and the rise of home-based infusion care
    • Lessons from leadership roles across national providers
    • Marc’s take on upcoming challenges and opportunities in infusion pharmacy
    Show More Show Less
    50 mins
  • Beyond the Drip: Inside IgNS National Conference, the Super Bowl of Ig Therapy

    Beyond the Drip: Inside IgNS National Conference, the Super Bowl of Ig Therapy
    Oct 2 2025
    Beyond the Drip: Elevating Ig Therapy Through Education and Standards Welcome to Beyond the Drip, where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired.     In episode 12 of Beyond the Drip, hosts Jon Love, Paula Roth, Brandon Carpenter, Pam McIntyre and Brian O’Sullivan welcome Luba Sobolevski, CEO and founder of IgNS, and Chief Clinical Officer Amy Clarke to discuss the evolving world of immunoglobulin (Ig) therapy and the 14th annual IgNS conference. The conversation highlights why IgNS was founded: to fill critical gaps in clinician education and standardize practices for a complex, lifelong therapy. Unlike fields such as oncology, Ig therapy historically offered limited training, leaving nurses and pharmacists underprepared to manage patient care and navigate regulatory and payer requirements. The IgNS conference, often called the “Super Bowl” of Ig therapy, brings together every sector of the industry from manufacturers and distributors to clinicians, pharmacists and infusion centers. Attendees can choose from business and clinical tracks, gaining guidance on revenue cycle management, documentation and legally defensible standards of practice. The discussion also explores how AI and technology are transforming care, from speech-to-text documentation and data analysis to wearable monitoring, while emphasizing that clinical judgment remains irreplaceable. Patient-focused initiatives, including education and surveys, ensure standards translate into safer, more effective care. Key Takeaways: Ig therapy is highly complex, with multiple indications, dosing protocols and routes of administration, creating unique challenges for clinicians and payers. Standardized education and competency frameworks help clinicians deliver safer, patient-centered care. The IgNS conference provides actionable guidance for clinical and revenue cycle professionals, including documentation, prior authorizations and payer collaboration. AI can streamline workflows and enhance decision-making but must be paired with expert clinical oversight. Patient education and feedback are essential to measure the impact of standards on care and outcomes. This episode offers insights into how IgNS is advancing Ig therapy standards, supporting clinicians and improving patient care. Listen to the full conversation on Beyond the Drip and subscribe to stay informed on the innovations shaping infusion care. Guest Speakers:Luba Sobolevsky, Pharm.D., IgCP®, President | CEO at Immunoglobulin National Society Dr. Luba Sobolevsky is the President and Chief Executive Officer of the Immunoglobulin National Society (IgNS), the central, standards-setting healthcare organization in the field of Ig therapy and biologics. Dr. Sobolevsky has over 25 years of diverse leadership experience across the healthcare field, including clinical practice, education, and pharmaceutical industry. She oversees IgNS’ strategic initiatives and the development of comprehensive programs and resources that promote best clinical practices and optimal patient outcomes. She is responsible for expanding and improving interdisciplinary and industry-wide collaboration and alliances.Dr. Sobolevsky leads IgNS’ Patient 360 division, dedicated to patient advocacy, education and outcomes research. She has been actively engaged in research and publication in areas of optimizing immunoglobulin practice, patient experience, health equity, healthcare team competencies, and the improvement of screening and diagnosis of rare diseases. Dr. Sobolevsky holds a PharmD degree from the University of Southern California and a BA from the University of California, Los Angeles. Amy E. Clarke, DNP RN IgCN®, Chief Clinical Officer at Immunoglobulin National Society Amy Clarke brings over 30 years of nursing experience, with a strong foundation in both clinical care and operational leadership. Her work has focused extensively on advancing immunoglobulin and infusion nursing practice, and she has had the opportunity to collaborate and present alongside respected colleagues at national and international conferences, including those hosted by NHIA, INS, ACAAI, and, of course, the Immunoglobulin National Society (IgNS).Dr. Clarke has contributed to the development of best practices in immunoglobulin therapy through co-authored publications and her involvement on several IgNS committees, including those responsible for the Ig Therapy Standards of Practice and the certification programs for nurses and pharmacists.Beyond the Drip Co-hosts:Paula Roth, VP of Pharmacy Services at ProchantAs Vice President of Pharmacy Operations at Prochant, Paula leads an expert team ...
    Show More Show Less
    1 hr and 5 mins
No reviews yet